158 related articles for article (PubMed ID: 38407551)
1. Functional Selection of Tau Oligomerization-Inhibiting Aptamers.
Wang B; Pan X; Teng IT; Li X; Kobeissy F; Wu ZY; Zhu J; Cai G; Yan H; Yan X; Liang M; Yu F; Lu J; Yang Z; Biondi E; Haskins W; Cao YC; Benner SA; Tan W; Wang KK
Angew Chem Int Ed Engl; 2024 Apr; 63(18):e202402007. PubMed ID: 38407551
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory RNA Aptamers of Tau Oligomerization and Their Neuroprotective Roles against Proteotoxic Stress.
Kim JH; Kim E; Choi WH; Lee J; Lee JH; Lee H; Kim DE; Suh YH; Lee MJ
Mol Pharm; 2016 Jun; 13(6):2039-48. PubMed ID: 27120117
[TBL] [Abstract][Full Text] [Related]
3. Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.
Yadikar H; Torres I; Aiello G; Kurup M; Yang Z; Lin F; Kobeissy F; Yost R; Wang KK
PLoS One; 2020; 15(7):e0224952. PubMed ID: 32692785
[TBL] [Abstract][Full Text] [Related]
4. Identification and Characterization of DNA Aptamers Specific for Phosphorylation Epitopes of Tau Protein.
Teng IT; Li X; Yadikar HA; Yang Z; Li L; Lyu Y; Pan X; Wang KK; Tan W
J Am Chem Soc; 2018 Oct; 140(43):14314-14323. PubMed ID: 30277395
[TBL] [Abstract][Full Text] [Related]
5. Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies.
Brunden KR; Trojanowski JQ; Lee VM
Nat Rev Drug Discov; 2009 Oct; 8(10):783-93. PubMed ID: 19794442
[TBL] [Abstract][Full Text] [Related]
6. Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders.
Kaur P; Khera A; Alajangi HK; Sharma A; Jaiswal PK; Singh G; Barnwal RP
Mol Neurobiol; 2023 Mar; 60(3):1690-1720. PubMed ID: 36562884
[TBL] [Abstract][Full Text] [Related]
7. Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.
Šimić G; Babić Leko M; Wray S; Harrington C; Delalle I; Jovanov-Milošević N; Bažadona D; Buée L; de Silva R; Di Giovanni G; Wischik C; Hof PR
Biomolecules; 2016 Jan; 6(1):6. PubMed ID: 26751493
[TBL] [Abstract][Full Text] [Related]
8. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
Jiang T; Yu JT; Zhu XC; Zhang QQ; Cao L; Wang HF; Tan MS; Gao Q; Qin H; Zhang YD; Tan L
Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
[TBL] [Abstract][Full Text] [Related]
9. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
[TBL] [Abstract][Full Text] [Related]
10. Both secreted and the cellular levels of BDNF attenuated due to tau hyperphosphorylation in primary cultures of cortical neurons.
Atasoy İL; Dursun E; Gezen-Ak D; Metin-Armağan D; Öztürk M; Yılmazer S
J Chem Neuroanat; 2017 Mar; 80():19-26. PubMed ID: 27914953
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective Studies of Evodiamine in an Okadaic Acid-Induced Neurotoxicity.
Chou CH; Yang CR
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069531
[TBL] [Abstract][Full Text] [Related]
12. An inhibitor with GSK3β and DYRK1A dual inhibitory properties reduces Tau hyperphosphorylation and ameliorates disease in models of Alzheimer's disease.
Liu X; Lai LY; Chen JX; Li X; Wang N; Zhou LJ; Jiang XW; Hu XL; Liu WW; Jiao XM; Qi ZT; Liu WJ; Wu LM; Huang YG; Xu ZH; Zhao QC
Neuropharmacology; 2023 Jul; 232():109525. PubMed ID: 37004752
[TBL] [Abstract][Full Text] [Related]
13. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan inhibits disulfide tau oligomerization and ameliorates tau pathology in Tau
Lim S; Shin S; Sung Y; Lee HE; Kim KH; Song JY; Lee GH; Aziz H; Lukianenko N; Kang DM; Boesen N; Jeong H; Abdildinova A; Lee J; Yu BY; Lim SM; Lee JS; Ryu H; Pae AN; Kim YK
Exp Mol Med; 2023 Mar; 55(3):612-627. PubMed ID: 36914856
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies.
Jangampalli Adi P; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2021 Aug; 1867(8):166162. PubMed ID: 33940164
[TBL] [Abstract][Full Text] [Related]
16. Tau phosphorylation and aggregation as a therapeutic target in tauopathies.
Badiola N; Suárez-Calvet M; Lleó A
CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):727-40. PubMed ID: 20942789
[TBL] [Abstract][Full Text] [Related]
17. Okadaic acid-induced tau hyperphosphorylation and the downregulation of Pin1 expression in primary cortical neurons.
Metin-Armağan D; Gezen-Ak D; Dursun E; Atasoy İL; Karabay A; Yılmazer S; Öztürk M
J Chem Neuroanat; 2018 Oct; 92():41-47. PubMed ID: 29860071
[TBL] [Abstract][Full Text] [Related]
18. Extracellular Vesicles Isolated from Familial Alzheimer's Disease Neuronal Cultures Induce Aberrant Tau Phosphorylation in the Wild-Type Mouse Brain.
Aulston B; Liu Q; Mante M; Florio J; Rissman RA; Yuan SH
J Alzheimers Dis; 2019; 72(2):575-585. PubMed ID: 31594233
[TBL] [Abstract][Full Text] [Related]
19. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
[TBL] [Abstract][Full Text] [Related]
20. HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.
Sepulveda-Diaz JE; Alavi Naini SM; Huynh MB; Ouidja MO; Yanicostas C; Chantepie S; Villares J; Lamari F; Jospin E; van Kuppevelt TH; Mensah-Nyagan AG; Raisman-Vozari R; Soussi-Yanicostas N; Papy-Garcia D
Brain; 2015 May; 138(Pt 5):1339-54. PubMed ID: 25842390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
